Premature and Low Birth Weight Infants Face Increased Sepsis Risk: Study
Researchers note that infection rates have declined as better infection controls among premature infants see wider use in the U.S., but more could be done
Tag Archives: Premature Birth
-
-
Makena Approval Officially Withdrawn by FDA After Concerns About Pregnancy Drug’s Benefits
FDA announced the Makena withdrawal after post-marketing studies failed to show the pregnancy drug provides any benefits in preventing preterm births
-
Pregnancy Drug Makena Removed From Market Amid Concerns About Lack of Benefits Preventing Premature Birth, Unnecessary Risks for Women
Experts have determined the pregnancy drug Makena provides little to no benefit and puts pregnant mothers and their children at risk of adverse health events.
-
Health Experts Question Why Makena is Still on the Market Despite FDA Advisors Recommendation to Recall Pregnancy Drug
The manufacturer claims it is trying to provide help to an underserved population of black women, yet raised the price of Makena from $15 to $15,000 when it bought the rights to the drug, critics note.
-
Makena Recall Recommended By FDA Panel Due to Ineffectiveness Reducing Preterm Birth Risk
Lack of any clinical benefits from the drug reducing preterm births has resulted in calls for Makena to be removed from the market in U.S.
-
Similac and Enfamil Caused Preterm Baby to Suffer Long-Term NEC Complications, Lawsuit Claims
Abbott and Mead Johnson put preemies at risk of long-term NEC complications without warning parents or healthcare providers about the risks of cow's milk based formula, according to the lawsuit.
-
Mother of Premature Infant Twins Filed NEC Lawsuit Against Makers of Similac, Enfamil
Complications led to one of the twins dying at less than a month old, according to the NEC lawsuit
-
Premature Infant NEC Lawsuit Alleges Formula Caused Newborn’s Death
Makers of Similac and Enfamil face a lawsuit alleging a premature infant NEC diagnosis was caused by the formula products
-
FDA Hearing To Determine if Makena Is Allowed Back On The Market
In 2019, a panel of FDA scientific advisors determined that the risk of Makena side effects outweigh any benefits for expecting mothers.
-
Necrotizing Enterocolitis and Respiratory Issues Among Top Premature Infant Mortality Causes: JAMA
Necrotizing enterocolitis was linked to a seven-fold increased risk of death among premature infants, the study found.
